Bessemer Group
HQL

Bessemer Group’s abrdn Life Sciences Investors HQL Stock Holding History

Bessemer Group’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-937
Closed -$15K – 2603
2025
Q3 		$15K Hold
937
– – ﹤0.01% 1802
2025
Q2 		$12K Hold
937
– – ﹤0.01% 1742
2025
Q1 		$12K Hold
937
– – ﹤0.01% 1701
2024
Q4 		$12K Hold
937
– – ﹤0.01% 1692
2024
Q3 		$14K Hold
937
– – ﹤0.01% 1580
2024
Q2 		$13K Hold
937
– – ﹤0.01% 1456
2024
Q1 		$13K Sell
937
-450
-32% -$6.22K ﹤0.01% 1504
2023
Q4 		$19K Sell
1,387
-238
-15% -$2.93K ﹤0.01% 1479
2023
Q3 		$21K Buy
1,625
+688
+73% +$9.05K ﹤0.01% 1473
2023
Q2 		$13K Hold
937
– – ﹤0.01% 1601
2023
Q1 		$13K Sell
937
-143
-13% -$2.04K ﹤0.01% 1445
2022
Q4 		$15K Sell
1,080
-6,650
-86% -$96.3K ﹤0.01% 1369
2022
Q3 		$106K Hold
7,730
– – ﹤0.01% 1014
2022
Q2 		$110K Hold
7,730
– – ﹤0.01% 1001
2022
Q1 		$128K Hold
7,730
– – ﹤0.01% 928
2021
Q4 		$149K Hold
7,730
– – ﹤0.01% 915
2021
Q3 		$161K Hold
7,730
– – ﹤0.01% 833
2021
Q2 		$166K Hold
7,730
– – ﹤0.01% 834
2021
Q1 		$152K Buy
7,730
+937
+14% +$19.3K ﹤0.01% 800
2020
Q4 		$134K Hold
6,793
– – ﹤0.01% 809
2020
Q3 		$119K Hold
6,793
– – ﹤0.01% 820
2020
Q2 		$122K Hold
6,793
– – ﹤0.01% 1214
2020
Q1 		$102K Hold
6,793
– – ﹤0.01% 1118
2019
Q4 		$118K Sell
6,793
-36
-0.5% -$591 ﹤0.01% 1159
2019
Q3 		$103K Buy
6,829
+304
+5% +$4.87K ﹤0.01% 1171
2019
Q2 		$110K Hold
6,525
– – ﹤0.01% 1193
2019
Q1 		$112K Sell
6,525
-7,649
-54% -$132K ﹤0.01% 1115
2018
Q4 		$214K Buy
+14,174
New +$250K ﹤0.01% 960

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bessemer Group's HQL Position: Q4 2025 in Review

Bessemer Group sold out of abrdn Life Sciences Investors (HQL) in Q4 2025, closing a stake of 937 shares — an estimated $15K sold.

Bessemer Group first reported a position in HQL in Q4 2018 and held it in 28 quarters. The position peaked at $214K in Q4 2018. 73 funds tracked by Wall St. Rank hold HQL as of Q4 2025.

  • Bessemer Group reported no remaining abrdn Life Sciences Investors position as of Q4 2025 after selling out during the quarter.
  • Bessemer Group sold 937 abrdn Life Sciences Investors shares in Q4 2025, an estimated $15K.
  • Bessemer Group first reported a position in abrdn Life Sciences Investors in Q4 2018 and held it in 28 quarters.
  • Bessemer Group's abrdn Life Sciences Investors position peaked at $214K in Q4 2018.
  • 73 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2025.

Based on Bessemer Group's 13F filing for Q4 2025, filed 5 Feb 2026.